DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

A new focus on dermatology, ophthalmology, and gastroenterology will pave ways for many untapped opportunities that Viatris can utilize with its scale and manufacturing power. We believe Viatris is in ...

Organon will also make additional payments of up to $950m on meeting commercial milestones, as well as tiered royalties on net product sales to Dermavant shareholders. Organon CEO Kevin Ali stated: ...

Oct. 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company ... revenue is dependent mainly upon sales of our ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Oct 23 (Reuters) - Merck (MRK.N), opens new tab has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm ...

A dedicated team gets critical healthcare products from manufacturers to patients while ensuring an efficient flow of funds between payers and pharma. Visit www.AscellaHealth.com. CHAPPER healthcare ...

Every brand seems to be bringing out the latest anti-wrinkle, anti-ageing, SPF, hyaluronic acid, salmon sperm products that can reduce sun damage, reduce signs of ageing, reduce you to looking like a ...